Table 1 Patients' Characteristics
Age | Gender | Dosage ( μ g) | Type of operation | Preoperative therapy | Postoperative therapy | Side effects (CTC grade)/relationship | OS (months) | Status | |
|---|---|---|---|---|---|---|---|---|---|
1 | 63 | M | 20 | R2 | CT, RCT, IORT | CT | — | 38.0 | Alive |
7 | 67 | M | 30 | Palliative | IORT | RCT | — | 31.3 | Alive |
5 | 63 | M | 25 | Palliative | CT, RCT, IORT | CT | Asystole (3), possible | 29.3 | Died |
3 | 74 | M | 20 | R2 | — | CT | — | 20.4 | Died |
8 | 69 | F | 20 | Palliative | IORT | CT | — | 17.4 | Died |
10 | 68 | M | 20 | Palliative | — | Hyper-thermia | — | 9.3 | Died |
2 | 37 | F | 20 | R2 | — | CT | — | 9.0 | Died |
4 | 73 | M | 25 | R2 | RCT, IORT | — | Myocardial infarction (4), not assessable | 6.5 | Died |
9 | 69 | F | 25 | Palliative | — | — | — | 1.8 | Died |
6 | 69 | F | 30 | R2 | RCT, IORT | — | Endotoxin-like shock (4), probably | 1.6 | Died |
